Want to join the conversation?
Mark Weintraub of Buckingham Research asks about the expected pace on share repurchase. $WY said that $2Bil of the $2.5Bil, the company would do on an accelerated basis. Once that's completed, $WY will re-evaluate the timing on the additional $500MM. The company will draw down on the term loan and use asset sales.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.